In a large cohort study of 577 patients with classical NMDARe, whose median age at onset was 21 years (44), we noted that patients with MS or AQP4-positive NMOSD overlap tended to be slightly older than those with classical NMDARe. Here, AQP4 is linked to myeloid sarcoma.